Gerald Klein, M.D.
Gerald L. Klein, MD, is acting Chief Medical Officer at ArunA Biomedical Inc. He is an expert in Medical Affairs and Clinical Development and has published numerous scientific papers. Prior to joining ArunA, Dr. Klein was a professor of Medicine and Pediatrics (Division of Basic and Applied Immunology) at University California, Irvine, and he was a founder and the CEO of Entera Health, Inc. He was also the Chief Medical Officer of Talecris/Grifols, as well as VP of Medical and Clinical Affairs at Dey/Merck KgAa, Clingenix, Specialty Labs, a founder and EVP Pathway Diagnostics, and Oxygen Biotherapeutic/Tanex.
Dr. Klein began his career in the industry by founding a CRO, San Diego Clinical Research (SDCRA), where he was CEO and Chief Medical Officer. SDCRA was sold to Quintiles and Dr. Klein, served as a SVP at Quintiles. He has extensive experience in CNS disease and has been involved in several clinical trials investigating new treatments for ischemic stroke. Dr. Klein has also been on the board of directors of Nanocorp, Oxygen Biotherapeutics (Tanex Biotechnology) and the American College of Allergy Asthma and Clinical Immunology.